Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles.

Takuro Hirano Eri Arai Mao Fujimoto Yuji Nakayama Ying Tian Nanako Ito Takeshi Makabe Wataru Yamagami Nobuyuki Susumu Daisuke Aoki Yae Kanai

Published in: Journal of gynecologic oncology (2022)

may be applicable to recurrence risk estimation for patients aged 40 years or less with endometrial cancer, regardless of tumor cell content, even if formalin-fixed paraffin-embedded biopsy or curettage materials are used.

Keyphrases

endometrial cancer
early onset
dna methylation
genome wide
end stage renal disease
late onset
ejection fraction
newly diagnosed
chronic kidney disease
gene expression
prognostic factors
copy number
cell therapy